23 related articles for article (PubMed ID: 22267286)
1. Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study.
Davidson LT; Engvall J; Chisalita SI; Östgren CJ; Nyström FH
Cardiovasc Diabetol; 2024 Jun; 23(1):200. PubMed ID: 38867292
[TBL] [Abstract][Full Text] [Related]
2. Trace Technology for Assays of Novel Biomarkers.
Bereciartua E
EJIFCC; 2011 Jan; 21(4):118-21. PubMed ID: 27683382
[TBL] [Abstract][Full Text] [Related]
3. Function Prediction of Peptide Toxins with Sequence-Based Multi-Tasking PU Learning Method.
Chu Y; Zhang H; Zhang L
Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36422985
[TBL] [Abstract][Full Text] [Related]
4. Underhydration Is Associated with Obesity, Chronic Diseases, and Death Within 3 to 6 Years in the U.S. Population Aged 51-70 Years.
Stookey JD; Kavouras SΑ; Suh H; Lang F
Nutrients; 2020 Mar; 12(4):. PubMed ID: 32224908
[TBL] [Abstract][Full Text] [Related]
5. Five-week yin yoga-based interventions decreased plasma adrenomedullin and increased psychological health in stressed adults: A randomized controlled trial.
Daukantaitė D; Tellhed U; Maddux RE; Svensson T; Melander O
PLoS One; 2018; 13(7):e0200518. PubMed ID: 30020987
[TBL] [Abstract][Full Text] [Related]
6. Deficiency in the anti-aging gene Klotho promotes aortic valve fibrosis through AMPKα-mediated activation of RUNX2.
Chen J; Lin Y; Sun Z
Aging Cell; 2016 Oct; 15(5):853-60. PubMed ID: 27242197
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin and tumour microenvironment.
Larráyoz IM; Martínez-Herrero S; García-Sanmartín J; Ochoa-Callejero L; Martínez A
J Transl Med; 2014 Dec; 12():339. PubMed ID: 25475159
[TBL] [Abstract][Full Text] [Related]
8. The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review.
Schuetz P; Marlowe RJ; Mueller B
Clin Chem Lab Med; 2015 Mar; 53(4):521-39. PubMed ID: 25252756
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive peptides with angiogenesis-regulating activity predict cancer risk in males.
Belting M; Almgren P; Manjer J; Hedblad B; Struck J; Wang TJ; Bergmann A; Melander O
Cancer Epidemiol Biomarkers Prev; 2012 Mar; 21(3):513-22. PubMed ID: 22267286
[TBL] [Abstract][Full Text] [Related]
10. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
[No Abstract] [Full Text] [Related]
11. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
12. MR-proANP and MR-proADM for risk stratification of patients with acute chest pain.
Tzikas S; Keller T; Ojeda FM; Zeller T; Wild PS; Lubos E; Kunde J; Baldus S; Bickel C; Lackner KJ; Münzel TF; Blankenberg S
Heart; 2013 Mar; 99(6):388-95. PubMed ID: 23213173
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive peptides associate with treatment outcome ofbevacizumab-containing therapy in metastatic colorectal cancer.
Hagman H; Bendahl PO; Melander O; Sundberg J; Johnsson A; Belting M
Acta Oncol; 2017 May; 56(5):653-660. PubMed ID: 28303751
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular biomarkers in patients with cancer and their association with all-cause mortality.
Pavo N; Raderer M; Hülsmann M; Neuhold S; Adlbrecht C; Strunk G; Goliasch G; Gisslinger H; Steger GG; Hejna M; Köstler W; Zöchbauer-Müller S; Marosi C; Kornek G; Auerbach L; Schneider S; Parschalk B; Scheithauer W; Pirker R; Drach J; Zielinski C; Pacher R
Heart; 2015 Dec; 101(23):1874-80. PubMed ID: 26416836
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
